Seeking Alpha

Jack Haddad's  Instablog

Jack Haddad
Send Message
Jack Haddad
  • AMLN is surging 9.5% today. 3 comments
    Jun 26, 2009 11:09 AM

    Does anyone has any link to any news?  I don't see any.  But I'm not sorry that I bought yesterday at 12.60

Back To Jack Haddad's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (3)
Track new comments
  • Alice4321us
    , contributor
    Comments (30) | Send Message
     
    On Monday FDA decides on some Drug approvals. May be insiders know something and are buying the shares ahead of it. Volume is pretty good so far.
    Excellent trade.
    26 Jun 2009, 11:28 AM Reply Like
  • Jack Haddad
    , contributor
    Comments (96) | Send Message
     
    Author’s reply » Alice, there is isn't any news out on AMLN today... I couldn't find a single link. I have ben contacting my sources, but to no avail... That is what prompted me to lock profits quickly.

     

    On Jun 26 11:28 AM Alice4321us wrote:

     

    > On Monday FDA decides on some Drug approvals. May be insiders know
    > something and are buying the shares ahead of it. Volume is pretty
    > good so far.
    > Excellent trade.
    26 Jun 2009, 12:27 PM Reply Like
  • Alice4321us
    , contributor
    Comments (30) | Send Message
     
    Shares in French drug maker Sanofi-Aventis S.A. (SNY, $28.01, -$2.20, -7.28%) fell as concerns surrounding the safety of its blockbuster diabetes drug Lantus gathered speed. A note published Thursday by UBS said UBS's research team investigated the possibility Lantus could pose a safety risk and concluded that such risks are only theoretical. But he added that discussions with doctors had revealed a "number of long-established safety concerns, in particular that Lantus use may promote cancer." Amylin Pharmaceuticals Inc. (AMLN, $13.69, +$1.10, +8.74%) gained on the speculation, as it could encourage increased use of Byette, sold by Amylin and Eli Lilly & Co. (LLY, $35.28, -$0.05, -0.14%).

     

    Source: online.wsj.com/article...
    27 Jun 2009, 12:19 AM Reply Like
Full index of posts »
Latest Followers

StockTalks

  • Market technicals: I'm accumulating both QID and DXD as the DOW and nasdaq look tired. We have not been able to surpass 10479.
    Dec 23, 2009
  • Amln: today's pullback is a great entry hedged by writing Jan 12.50 calls. Last week's results of Byetta far exceeded epxectations.
    Dec 23, 2009
  • QID: added more to my core position at 20.48. Nasdaq is topping out and is tiring.
    Dec 11, 2009
More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.